ASPIRIN
-
aspirin tablet
Advance Pharmaceutical Inc.
(in each tablet)
Aspirin 81 mg (NSAID) *
*nonsteroidal anti-inflammatory drug
Pain Reliever
Reye’s Syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early signs of Reye’s syndrome, a rare but serious illness.
Allergy Alert: Aspirin may cause a severe allergic reaction which may include
Stomach Bleeding Warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
Do not use
Ask a doctor before use if
Ask a doctor or pharmacist before use if you are
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center right away.
DRINK A FULL GLASS OF WATER WITH EACH DOSE
croscarmellose sodium, D&C Yellow #10 (Al-Lake), HPMC, methacrylic acid copolymer, microcrystalline cellulose, polyethylene glycol, propylene glycol, PVP, silicon dioxide, sodium lauryl sulfate, corn starch, stearic acid, talc, titanium dioxide
Call 631-981-4600, 8.30am – 4.30 pm ET Monday-Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Safer for your stomach than pain or Buffered Aspirin
Manufactured by: Advance Pharmaceutical, Inc. Holtsville, NY 11742
NDC: 17714-121-12 – 120 Tablets
NDC: 17714-121-06 - 240 Tablets
ASPIRIN
aspirin tablet | ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part343 | 06/12/2022 |
Labeler - Advance Pharmaceutical Inc. (078301063) |
Registrant - Advance Pharmaceutical Inc. (078301063) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Advance Pharmaceutical Inc. | 078301063 | MANUFACTURE |